**Curium Pharma Establishes Global Headquarters at 2 Seaport Lane, Boston**
Curium Pharma, a leading radiopharmaceutical company, has secured a 6,982-square-foot sublease at Pembroke’s 2 Seaport Lane. The newly leased space in Boston’s Seaport District will serve as the company’s global headquarters, supporting its international team and ongoing advancements in cancer medicine.
“The Seaport proved to be an ideal location for Curium’s Global Headquarters, situating the team within one of Greater Boston’s most vibrant biotech submarkets, complemented by exceptional connectivity to Logan Airport,” said Steve James, Executive Vice President at Hunneman. “In a challenging macroeconomic environment, Boston continues to be a magnet for growing life science companies. This year, Hunneman has executed several leases for medical and life science companies, underscoring our role in supporting this critical sector of our local economy.”
Curium was represented in the transaction by Steve James and Peter Bean, both of Hunneman.
2 Seaport Lane features newly built, Class-A office space with scenic harbor views. Tenants enjoy premier onsite amenities, including a modernized lobby with an indoor winter garden and an underground parking garage.
